Neurocrine Biosciences
NBIX
#1323
Rank
HK$132.89 B
Marketcap
HK$1,322
Share price
2.64%
Change (1 day)
33.96%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of March 2026 : HK$38.47 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total assets are HK$38.47 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31HK$36.03 B24.82%
2024-12-31HK$28.87 B13.69%
2023-12-31HK$25.39 B37.21%
2022-12-31HK$18.50 B14.52%
2021-12-31HK$16.16 B20.17%
2020-12-31HK$13.44 B32.21%
2019-12-31HK$10.17 B30.78%
2018-12-31HK$7.77 B21.75%
2017-12-31HK$6.38 B125.63%
2016-12-31HK$2.83 B-23.07%
2015-12-31HK$3.67 B95.21%
2014-12-31HK$1.88 B57.17%
2013-12-31HK$1.19 B-21.04%
2012-12-31HK$1.51 B41.35%
2011-12-31HK$1.07 B-4.38%
2010-12-31HK$1.12 B104.69%
2009-12-31HK$0.54 B-39.87%
2008-12-31HK$0.91 B-57.66%
2007-12-31HK$2.15 B-28.83%
2006-12-31HK$3.03 B-19.09%
2005-12-31HK$3.74 B-7.17%
2004-12-31HK$4.03 B-6.2%
2003-12-31HK$4.30 B106.94%
2002-12-31HK$2.07 B-23.03%
2001-12-31HK$2.70 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
HK$1.628 T 4,131.75%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$1.070 T 2,681.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$914.25 B 2,276.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$22.98 B-40.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$58.25 M-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$11.15 B-71.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$67.56 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
HK$155.40 B 303.88%๐Ÿ‡ฌ๐Ÿ‡ง UK